U.S. Markets closed
  • S&P Futures

    3,450.75
    +18.50 (+0.54%)
     
  • Dow Futures

    28,318.00
    +136.00 (+0.48%)
     
  • Nasdaq Futures

    11,725.00
    +64.25 (+0.55%)
     
  • Russell 2000 Futures

    1,625.50
    +10.70 (+0.66%)
     
  • Crude Oil

    41.51
    +0.05 (+0.12%)
     
  • Gold

    1,922.60
    +7.20 (+0.38%)
     
  • Silver

    25.17
    +0.19 (+0.74%)
     
  • EUR/USD

    1.1846
    +0.0017 (+0.1421%)
     
  • 10-Yr Bond

    0.7970
    +0.0360 (+4.73%)
     
  • Vix

    29.35
    +0.17 (+0.58%)
     
  • GBP/USD

    1.2974
    +0.0027 (+0.2115%)
     
  • USD/JPY

    105.3650
    -0.1050 (-0.0996%)
     
  • BTC-USD

    12,144.20
    +1,087.19 (+9.83%)
     
  • CMC Crypto 200

    243.40
    +4.48 (+1.88%)
     
  • FTSE 100

    5,889.22
    +4.57 (+0.08%)
     
  • Nikkei 225

    23,676.90
    +109.86 (+0.47%)
     

Edwards Lifesciences Corp (EW) Chairman & CEO Michael A Mussallem Sold $5.7 million of Shares

GuruFocus.com
·3 mins read

- By insider

Chairman & CEO of Edwards Lifesciences Corp (30-Year Financial, Insider Trades) Michael A Mussallem (insider trades) sold 68,550 shares of EW on 10/09/2020 at an average price of $83.19 a share. The total sale was $5.7 million.


Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards Lifesciences Corp has a market cap of $52.16 billion; its shares were traded at around $83.90 with a P/E ratio of 72.14 and P/S ratio of 12.31. Edwards Lifesciences Corp had annual average EBITDA growth of 16.30% over the past ten years. GuruFocus rated Edwards Lifesciences Corp the business predictability rank of 3-star. GuruFocus has detected 1 severe warning sign with Edwards Lifesciences Corp. .

CEO Recent Trades:

  • Chairman & CEO Michael A Mussallem sold 68,550 shares of EW stock on 10/09/2020 at the average price of $83.19. The price of the stock has increased by 0.85% since.

  • Chairman & CEO Michael A Mussallem sold 68,550 shares of EW stock on 09/29/2020 at the average price of $78.74. The price of the stock has increased by 6.55% since.

CFO Recent Trades:

  • CVP, CFO Scott B. Ullem sold 33,150 shares of EW stock on 09/28/2020 at the average price of $78.11. The price of the stock has increased by 7.41% since.

  • CVP, CFO Scott B. Ullem sold 33,150 shares of EW stock on 09/15/2020 at the average price of $83.43. The price of the stock has increased by 0.56% since.

  • CVP, CFO Scott B. Ullem sold 26,700 shares of EW stock on 09/14/2020 at the average price of $82.21. The price of the stock has increased by 2.06% since.

Directors and Officers Recent Trades:

  • CVP, Japan & Intercontinental Huimin Wang sold 11,733 shares of EW stock on 10/09/2020 at the average price of $82.6. The price of the stock has increased by 1.57% since.

  • CVP,Strategy/Corp Development Donald E Jr Bobo sold 13,074 shares of EW stock on 10/09/2020 at the average price of $82.61. The price of the stock has increased by 1.56% since.

  • CVP, TAVR Larry L Wood sold 10,698 shares of EW stock on 10/01/2020 at the average price of $80.38. The price of the stock has increased by 4.38% since.

  • CVP,Strategy/Corp Development Donald E Jr Bobo sold 13,074 shares of EW stock on 09/11/2020 at the average price of $82.45. The price of the stock has increased by 1.76% since.

  • CVP, Japan & Intercontinental Huimin Wang sold 11,730 shares of EW stock on 09/11/2020 at the average price of $82.44. The price of the stock has increased by 1.77% since.

For the complete insider trading history of EW, click here

.This article first appeared on GuruFocus.